Search research articles
Contact Us
Filters
Showing results (371-380 of 659) with videos related to
Page
of 66
Sort By:
The American Journal of Pathology
|
July 5, 2017
Characterization of Normal Murine Carpal Bone Development Prompts Re-Evaluation of Pathologic Osteolysis as the Cause of Human Carpal-Tarsal Osteolysis Disorders
Syndia Lazarus, Hsu-Wen Tseng, Felicity Lawrence, et al.
Biochemical and Biophysical Research Communications
|
December 3, 1999
Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh
N R Wall, R M Mohammad, S M Nabha, et al.
Cancer Research
|
August 1, 1990
Development of an in vitro analogue of initiated mouse epidermis to study tumor promoters and antipromoters
H Hennings, V A Robinson, D M Michael, et al.
Leukemia
|
October 1, 1992
Dolastatin 10 and dolastatin 15: effects of two natural peptides on growth and differentiation of leukemia cells
K G Steube, D Grunicke, T Pietsch, et al.
Cancer Immunology, Immunotherapy : CII
|
October 1, 1994
Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitro
C Scheid, J Prendiville, G Jayson, et al.
Bioorganic & Medicinal Chemistry
|
July 6, 2010
Antineoplastic agents 582. Part 1: Isolation and structure of a cyclobutane-type sesquiterpene cancer cell growth inhibitor from Coprinus cinereus (Coprinaceae)
George R Pettit, Yanhui Meng, Robin K Pettit, et al.
Antimicrobial Agents and Chemotherapy
|
January 27, 2004
Differential gene expression in auristatin PHE-treated Cryptococcus neoformans
Tanja Woyke, Michael E Berens, Dominique B Hoelzinger, et al.
Cancer Research
|
April 25, 1992
In vivo administration of bryostatin 1, a protein kinase C activator, decreases murine resistance to Salmonella typhimurium
A S Kraft, V Adler, P Hall, et al.
Tumori
|
June 30, 1992
The effects of the macrocyclic lactone bryostatin-1 on leukemic cells in vitro
V Gebbia, P Citarrella, V Miserendino, et al.
Anti-Cancer Drugs
|
July 27, 2000
Effects of combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines
S M Nabha, N R Wall, R M Mohammad, et al.
Page
of 66
Search research articles
Search
Showing results (371-380 of 659) with videos related to
Sort By:
Page
of 66
The American Journal of Pathology
|
July 5, 2017
Characterization of Normal Murine Carpal Bone Development Prompts Re-Evaluation of Pathologic Osteolysis as the Cause of Human Carpal-Tarsal Osteolysis Disorders
Syndia Lazarus, Hsu-Wen Tseng, Felicity Lawrence, et al.
Biochemical and Biophysical Research Communications
|
December 3, 1999
Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh
N R Wall, R M Mohammad, S M Nabha, et al.
Cancer Research
|
August 1, 1990
Development of an in vitro analogue of initiated mouse epidermis to study tumor promoters and antipromoters
H Hennings, V A Robinson, D M Michael, et al.
Leukemia
|
October 1, 1992
Dolastatin 10 and dolastatin 15: effects of two natural peptides on growth and differentiation of leukemia cells
K G Steube, D Grunicke, T Pietsch, et al.
Cancer Immunology, Immunotherapy : CII
|
October 1, 1994
Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitro
C Scheid, J Prendiville, G Jayson, et al.
Bioorganic & Medicinal Chemistry
|
July 6, 2010
Antineoplastic agents 582. Part 1: Isolation and structure of a cyclobutane-type sesquiterpene cancer cell growth inhibitor from Coprinus cinereus (Coprinaceae)
George R Pettit, Yanhui Meng, Robin K Pettit, et al.
Antimicrobial Agents and Chemotherapy
|
January 27, 2004
Differential gene expression in auristatin PHE-treated Cryptococcus neoformans
Tanja Woyke, Michael E Berens, Dominique B Hoelzinger, et al.
Cancer Research
|
April 25, 1992
In vivo administration of bryostatin 1, a protein kinase C activator, decreases murine resistance to Salmonella typhimurium
A S Kraft, V Adler, P Hall, et al.
Tumori
|
June 30, 1992
The effects of the macrocyclic lactone bryostatin-1 on leukemic cells in vitro
V Gebbia, P Citarrella, V Miserendino, et al.
Anti-Cancer Drugs
|
July 27, 2000
Effects of combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines
S M Nabha, N R Wall, R M Mohammad, et al.
Page
of 66